Related Experiment Videos
[Zinc sulfate in the complex treatment of children with cerebral palsy]
Insights
Zinc sulfate supplementation improved metabolism and immune function in children with spastic diplegia cerebral palsy. This intervention enhanced clinical status and body defense properties in pediatric patients.
Area of Science:
- Pediatric Neurology
- Metabolic Disorders
- Nutritional Science
Context:
- Cerebral palsy, specifically spastic diplegia, affects children's motor function and can be associated with metabolic disturbances.
- Disorders in zinc metabolism are prevalent in children with moderate to severe spastic diplegia.
- Standard rehabilitation may not fully address underlying metabolic abnormalities.
Purpose:
- To investigate the efficacy of zinc sulfate supplementation in children with spastic diplegia cerebral palsy.
- To evaluate the impact of zinc sulfate on metabolic processes, clinical outcomes, and immune function.
- To determine if zinc supplementation can enhance the effectiveness of conventional treatment.
Summary:
- Ninety-six children (3-14 years) with spastic diplegia cerebral palsy were studied.
- A group of 20 children received zinc sulfate orally alongside standard treatment, while 38 formed a control group receiving only standard care.
- The study assessed metabolic profiles, clinical status, and immune markers.
Impact:
- Zinc sulfate administration in children with spastic diplegia improved metabolic processes.
- Supplementation led to enhanced clinical health status and strengthened body defense properties.
- Zinc sulfate shows potential as an adjunctive therapy for pediatric cerebral palsy.
Abstract:
Ninety-six children aged 3 to 14 years with cerebral paralysis in the form of spastic diplegia of medium and grave intensity were examined. The majority of the children showed disorders of zinc metabolism and of other types of metabolism. To correct metabolic abnormalities, 20 children received zinc sulfate in biological doses per os in addition to the main complex of treatment measures. 38 children suffering from cerebral paralysis made up the control group and were given a complex of routine rehabilitation treatment measures. It has been established that introduction of the biotic doses of zinc sulfate into the complex of therapeutic measures for children with cerebral paralysis in the form of spastic diplegia favoured the improvement of metabolic processes, the clinical health status of the children, and enhancement of the body defence properties.